Infant Bacterial Therapeutics AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.02.22	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2021 (GlobeNewswire)
19.01.22	The Connection Study continues after pre-scheduled Data Monitoring Committee (DMC) review (GlobeNewswire)
10.01.22	Infant Bacterial Therapeutics today announces that new patent protection is granted in Australia (GlobeNewswire)
27.12.21	Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong (GlobeNewswire)
10.12.21	Infant Bacterial Therapeutics CFO leaves the company (GlobeNewswire)
06.12.21	A Blinded Evaluation of the Connection Study – Sustained Feeding Tolerance (SFT) Correlates to Clinical Outcomes (GlobeNewswire)
29.10.21	Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bacterial Therapeutics (IBT). (GlobeNewswire)
29.10.21	Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021 (GlobeNewswire)
30.09.21	Next recruitment milestone reached in IBT’s Phase III Study. (GlobeNewswire)
22.09.21	After safety review The Connection study is now again open to recruit the smallest infants. (GlobeNewswire)
10.09.21	Infant Bacterial Therapeutics today announces that a new patent is granted in Mexico (GlobeNewswire)
25.08.21	Recruitment of the smallest infants in the Connection study paused (GlobeNewswire)
13.08.21	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021 (GlobeNewswire)
13.07.21	Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO (GlobeNewswire)
20.05.21	Infant Bacterial Therapeutics CFO leaves the company (GlobeNewswire)
06.05.21	Annual General Meeting of Infant Bacterial Therapeutics CEO speech (GlobeNewswire)
04.05.21	Annual General Meeting of Infant Bacterial Therapeutics (GlobeNewswire)
04.05.21	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2021 (GlobeNewswire)
29.04.21	Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams (GlobeNewswire)
15.04.21	Infant Bacterial Therapeutics receives additional patent protection in China (GlobeNewswire)
09.04.21	Infant Bacterial Therapeutics publishes Annual Report for 2020 (GlobeNewswire)
01.04.21	Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics (GlobeNewswire)
10.02.21	Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed - an update about the clinical development of IBP-9414 (GlobeNewswire)
09.02.21	Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan (GlobeNewswire)
05.02.21	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2020 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Infant Bacterial Therapeutics AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten